Trial Profile
Princess Margaret Cancer Centre 18F-DCFPyL PET Registry
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 11 Apr 2024
Price :
$35
*
At a glance
- Drugs Piflufolastat F18 (Primary)
- Indications Carcinoma; Prostate cancer
- Focus Diagnostic use
- Acronyms PM-PPR
- 05 Apr 2024 Planned primary completion date changed from 31 Dec 2023 to 31 Dec 2024.
- 01 Sep 2022 Results assessing performance of 18F-DCFPyL PET/CT or PET/MRI with bone scan and CT with or without multiparametric MRI using data from two clinical studies: NCT03535831 and NCT03718260 published in the Radiology
- 19 Apr 2021 Status changed from recruiting to active, no longer recruiting.